Tag: Biotechnology

ADOCIA
Europe

ADOCIA Announces Appointment of Mathieu‑William Gilbert as Chief Financial Officer

LYON, France–(BUSINESS WIRE)–Regulatory News: “We have had the time for a thorough transition with Mathieu, and I have come to appreciate his skills and strategic vision. Lastly, I would like to thank Gérard and Olivier for trusting me and for the intense and rewarding years we have spent together.” Post this Adocia (Euronext Paris: FR0011184241 – ADOC, the “Company”), a clinical-stage biopharmaceutical company focused on … Continue reading ADOCIA Announces Appointment of Mathieu‑William Gilbert as Chief Financial Officer

Impact Newswire
Accellix
United States

Accellix Appoints Greg Hamilton as Chief Executive Officer as Company Accelerates Growth in Cell Therapy and Blood Bank Markets

SAN JOSE, Calif. & JERUSALEM – Accellix, Inc., the leading sample to answer flow cytometry GMP platform company, is pleased to announce the appointment of Greg Hamilton as Chief Executive Officer and member of the Board effective September 23, 2024. He brings over 25 years of management experience in molecular diagnostics, life science tools, manufacturing and professional service industries as the company ramps growth in … Continue reading Accellix Appoints Greg Hamilton as Chief Executive Officer as Company Accelerates Growth in Cell Therapy and Blood Bank Markets

Impact Newswire
Prilenia
United States

Prilenia Appoints Rob Lauzen as Chief Financial Officer and Jason Marks as Chief Legal Officer

Expanded leadership team positioned to advance the company’s development and commercialization plans NAARDEN, The Netherlands & WALTHAM, Mass. – Prilenia Therapeutics B.V., a clinical stage biotechnology company focused on the urgent mission to develop novel therapeutics to slow the progression of neurodegenerative diseases and neurodevelopmental disorders, today announced the appointment of two key leaders to its management team – Mr. Rob Lauzen as Chief Financial … Continue reading Prilenia Appoints Rob Lauzen as Chief Financial Officer and Jason Marks as Chief Legal Officer

Impact Newswire
Novotech
United States

Novotech Earns Great Place to Work® Certification in the United States

BOSTON – Novotech, a global full-service clinical Contract Research Organization (CRO), is proud to announce that it has been certified as a Great Place to Work® in the United States. This award reflects Novotech’s commitment to fostering a flexible, inclusive, and innovative work environment where employees feel supported and empowered to contribute to the future of medical research. “Our employees are the heart of Novotech, … Continue reading Novotech Earns Great Place to Work® Certification in the United States

Impact Newswire
CorriXR Therapeutics
United States

CorriXR Therapeutics Appoints Jill Castilla to Its Board of Directors

OKLAHOMA CITY – CorriXR Therapeutics, Inc. (“CorriXR”), a biotherapeutics company developing unique genetic medicines that optimize the effectiveness of existing cancer treatments by knocking out genes responsible for resistance, today announced the appointment of Jill Castilla to its Board of Directors. Ms. Castilla brings visionary leadership as a nationally recognized innovator in finance and banking. “We are very pleased to welcome Jill to our Board … Continue reading CorriXR Therapeutics Appoints Jill Castilla to Its Board of Directors

Impact Newswire
Entact Bio
United States

Entact Bio Appoints Ruben Tommasi, Ph.D., as Chief Scientific Officer

Veteran drug developer and R&D leader with three decades of pharmaceutical and biotech experience to oversee development of targeted protein enhancement modality WATERTOWN, Mass. – Entact Bio, a company committed to improving the lives of patients by developing precision medicines that enhance the function of beneficial proteins, today announced the appointment of Ruben Tommasi, Ph.D., as Chief Scientific Officer. Dr. Tommasi joins Entact with three … Continue reading Entact Bio Appoints Ruben Tommasi, Ph.D., as Chief Scientific Officer

Impact Newswire
Mirador Therapeutics
United States

Mirador Therapeutics Appoints Gregg Gilbert as Chief Financial Officer

SAN DIEGO – Mirador Therapeutics, Inc., a next-generation precision medicine company focused on developing first-in-class or best-in-class therapeutics for immunology and inflammation (I&I), today announced the appointment of Gregg Gilbert as chief financial officer. Mr. Gilbert brings more than 25 years of leadership experience in biopharma equity research analysis and investment banking to the role. “Since launching earlier this year with over $400 million in … Continue reading Mirador Therapeutics Appoints Gregg Gilbert as Chief Financial Officer

Impact Newswire
BioDuro-Sundia
United States

BioDuro-Sundia Appoints Dr. Armin Spura as New Chief Executive Officer

IRVINE, Calif. – BioDuro-Sundia, a leading Contract Research, Development, and Manufacturing Organization (CRDMO), is pleased to announce the appointment of Dr. Armin Spura as its new Chief Executive Officer. Dr. Spura brings over two decades of experience in the life sciences and biotechnology sectors, with a proven track record of driving growth and innovation across global markets. With our CRDMO platform encompassing chemistry, biology, DMPK, … Continue reading BioDuro-Sundia Appoints Dr. Armin Spura as New Chief Executive Officer

Impact Newswire